Clinical trials
Clinical clinical trials
Below are recruiting clinical clinical trials, each written for real people, not researchers. We’re tracking 5,572 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07164170RecruitingPhase 2
Study of ABSK043 plus Glecirasib for advanced NSCLC
This trial tests a combination of two experimental drugs, ABSK043 and Glecirasib, for people with a specific type of advanced non-small cell lung cancer (NSCLC). The goal is to see if the combination works better than standard treatments.
Hefei, AnhuiAges 18 years+ - NCT07165223RecruitingPhase 3
Testing a new insulin for type 2 diabetes
This trial tests a new weekly insulin called GZR4 for people with type 2 diabetes who already use basal insulin. It aims to see how well it controls blood sugar and if it is safe.
Linyi, ShandongAges 18 years+ - NCT07166757RecruitingPhase 1/Phase 2
Study of XS411 for early-onset Parkinson's disease
This trial tests a new treatment called XS411 for people with early-onset Parkinson's disease (age 50 or younger at diagnosis). It is for those whose motor symptoms are not well controlled with standard medications and who may benefit from a neurosurgical procedure.
Shanghai, Shanghai MunicipalityAges 18–70 - NCT07167563Recruiting
Real-world lithium study for bipolar disorder
This study looks at how lithium works in everyday life for people with bipolar disorder. It aims to learn about real-world treatment patterns and outcomes.
AarhusAges 18 years+ - NCT07168096Recruiting
Emotional health and decision-making in cancer patients
This study tracks how anxiety and depression change over time in people with solid tumors. It aims to find risk factors and improve supportive care, while also exploring how much patients understand about their prognosis and want to be involved in decisions.
Santander, CantabriaAges 18 years+ - NCT07168122Recruiting
Salivary cortisol test for adrenal health
This study is building a reference range for a simple saliva test that measures cortisol, a hormone linked to stress and adrenal function. It may help diagnose conditions like Cushing's syndrome or adrenal insufficiency.
Shanghai, Shanghai MunicipalityAges 18–80 - NCT07168226RecruitingPhase 2
Trial of ASCA101 for Cancer-Related Weight Loss
This trial tests a new drug, ASCA101, for people with certain cancers who are experiencing unwanted weight loss (cachexia). It aims to see if the drug can help improve appetite and stabilize weight. Participants must have colorectal, ovarian, or lung cancer and meet specific weight loss criteria.
Seoul, Gangnam-guAges 19 years+ - NCT07168330Recruiting
How well does ankle replacement work? A long-term look
This study checks how well total ankle replacements work over time, using patient reports and X-rays. It may help you understand your own recovery and improve care for others.
MilanAges 18–90 - NCT07168616Recruiting
PSMA PET imaging for active surveillance in low-risk prostate cancer
This study uses a special imaging test (PSMA PET/CT) to better see if men with low-risk prostate cancer are good candidates for active surveillance (monitoring instead of immediate treatment). It helps doctors decide if watching the cancer closely is safe.
Istanbul, TurkeyAges 18 years+ - NCT07169019RecruitingEarly Phase 1
Probiotics and methotrexate for early psoriasis
This pilot study tests whether adding probiotics to standard methotrexate treatment improves symptoms in people newly diagnosed with chronic plaque psoriasis. It aims to see how the gut microbiome affects treatment response.
AlexandriaAges 18 years+ - NCT07169136Recruiting
GLP-1 medicine for PCOS in teens with obesity
This trial tests if a medicine called a GLP-1 agonist (like semaglutide) can help with hormone and ovulation problems in adolescent girls with PCOS and obesity. It aims to improve irregular periods and other PCOS symptoms.
Jacksonville, FloridaAges 12–18 - NCT07169500RecruitingPhase 1/Phase 2
CAR-T with or without stem cell transplant for young women with myeloma
This trial tests a new immune cell therapy (BCMA-CART) alone or combined with a stem cell transplant for women aged 18-55 with multiple myeloma. It aims to see if this treatment is safe and effective.
Tianjin, Tianjin MunicipalityAges 18–50 - NCT07169643RecruitingPhase 3
Darbepoetin trial for people waiting for a liver transplant
This trial tests if darbepoetin, a medicine that boosts red blood cells, can help people with anemia who are on the liver transplant waiting list. It may improve your strength and prepare you for surgery.
Barcelona, CataloniaAges 18–70 - NCT07169799Recruiting
Freezing spray for GAVE stomach bleeding
This study tests a freezing spray (Tru-Freeze) to treat GAVE, a condition that causes stomach bleeding. It may help people who need blood transfusions because of GAVE and have had few or no prior endoscopic treatments.
Jacksonville, FloridaAges 18 years+ - NCT07170150RecruitingPhase 3
A study of trontinemab for early Alzheimer's disease
This trial tests an investigational drug called trontinemab in people with early symptomatic Alzheimer's disease. It aims to see if it can slow down memory and thinking problems.
Phoenix, ArizonaAges 50–90 - NCT07170176Recruiting
PFO closure and migraine: can it help?
This trial tests if closing a common heart defect (PFO) can improve migraine symptoms and brain function. It compares people with migraine who get the closure procedure to those without migraine.
Luoyang, HenanAges 18–60 - NCT07170748Recruiting
Testing a new blood test for HIV, hepatitis B/C, and syphilis
This study evaluates a new blood test that checks for HIV, hepatitis B, hepatitis C, and syphilis all at once. It is designed to see how well the test works in different groups of people, including those with known infections and those without.
AbidjanAges 18 years+ - NCT07170800RecruitingPhase 2
Study of JDB0131 for drug-resistant TB
This trial tests a new tablet called JDB0131 for people with tuberculosis (TB) that is resistant to the antibiotic rifampicin. The goal is to see if it can effectively treat this hard-to-treat form of TB.
Wuhan, HubeiAges 14 years+ - NCT07172893RecruitingPhase 4
Dermabind TL for diabetic foot ulcers
This trial tests a new wound dressing called DermaBind TL for people with diabetic foot ulcers. It aims to see if the dressing helps heal these wounds, which can be hard to treat.
DeLand, FloridaAges 18–80 - NCT07173088Recruiting
Ankle exercise program after fracture surgery
This study tests a new exercise program called the Ankle Muscle Power (AMP) program to help people get back to full duty after an ankle fracture surgery. It aims to see if this program is effective and practical for recovery.
Lexington, KentuckyAges 18–50 - NCT07174206Recruiting
Smartwatch monitoring for heart patients
This trial tests a smartwatch tool to track heart rhythm and detect problems in people with heart disease. It may help find irregular heartbeats early during routine checkups.
São Paulo, São PauloAges 22 years+ - NCT07174219Recruiting
Return to sports after MCL knee surgery
This study tracks people who had surgery to reattach the medial collateral ligament (MCL) in the knee, alone or with other repairs. It measures how well and how safely they return to sports. If you had this surgery, you may help improve future care.
Bologna, BolognaAges 12–65 - NCT07174622Recruiting
Long-term results for renal denervation study
This study tracks patients who have uncontrolled high blood pressure and are on a steady medication plan. It checks how kidney nerve treatment (renal denervation) works in real life over time.
Boston, MassachusettsAges 18 years+ - NCT07175220RecruitingPhase 2
Study of SHR2554 tablets combined with other treatments for lung cancer
This trial tests a new drug combination for people with non-small cell lung cancer that has spread or cannot be removed by surgery. It aims to see if adding SHR2554 tablets to other anticancer treatments can help control the disease.
Guangzhou, GuangdongAges 18–75
Hear when a new Clinical trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for clinical?
- Yes. Clin2 currently lists 5,572 recruiting clinical studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a clinical trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a clinical trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.